Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance

Gastroenterology. 2009 Sep;137(3):1019-28. doi: 10.1053/j.gastro.2009.03.055. Epub 2009 Apr 1.

Abstract

Background & aims: Orally induced tolerance to environmental allergens prevents deleterious, systemic, delayed-type hypersensitivity responses via immune suppression mechanisms believed to include either anergy/deletion of specific effector T cells or active suppression by CD4(+)CD25(+) regulatory T cells (Tregs). The aim of this study was to investigate whether and how antigen (Ag) penetration through the gut orchestrates these 2 distinct mechanisms.

Methods: Using a model of allergic contact dermatitis (ACD) mediated by hapten-specific cytolytic CD8(+) T cells and a T-cell transfer model of contact hypersensitivity in CD3epsilon-deficient mice, we studied the outcome of Ag gavage on CD8(+) effectors and Tregs.

Results: Full protection from ACD by gavage with the relevant allergen required 2 coordinated events taking place first in gut-associated lymphoid tissues and then systemically. Allergen gavage induced deletion by plasmacytoid dendritic cells of a large fraction of Ag-specific CD8(+) T cells in liver and mesenteric lymph nodes and also triggered the suppressive function of Treg of secondary lymphoid organs. Residual Ag-specific CD8(+) T cells conditioned during this mucosal step are fully susceptible to suppression by activated Treg, which completely prevented their differentiation into ACD effectors, upon re-exposure to the allergen via the skin.

Conclusions: Thus, oral tolerance initiated in gut-associated lymphoid tissues by the plasmacytoid dendritic cells-mediated deletion of Ag-specific T cells is completed systemically by CD4(+)CD25(+) T cells. Biotherapies able to increase the susceptibility of effector T cells to the suppressive function of Treg may be valuable for the treatment of autoimmune and inflammatory diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adoptive Transfer
  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Dendritic Cells / immunology*
  • Dermatitis, Contact / immunology
  • Dinitrofluorobenzene / administration & dosage
  • Dinitrofluorobenzene / immunology
  • Female
  • Haptens / administration & dosage
  • Haptens / immunology
  • Immune Tolerance*
  • Immunization
  • Interleukin-10 / immunology
  • Interleukin-2 Receptor alpha Subunit / analysis
  • Liver / immunology
  • Lymph Nodes / immunology
  • Lymphocyte Subsets
  • Mesentery
  • Mice
  • Mice, Inbred C57BL
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • Haptens
  • Interleukin-2 Receptor alpha Subunit
  • Interleukin-10
  • Dinitrofluorobenzene